Market Players, Size, Technology, Report, Demand, and Trend Forecast to 2029 (2023)

Global Artificial Organs Market for Medical Bionic Implants, by Product (Visual Bionics, Auricular Bionics, Orthopedic Bionics, Cardiac Bionics, Neural/Brain Bionics), Attachment Method (Implantable, Externally Worn), Technology (Electronics, Mechanical), End User (Hospitals and Clinics, Research and Academic Institutes, others), – Sector Trends and Forecast until 2029

Market and size analysis

It has been observed that the increasing number of cases of organ failure has increased the demand for replaceable organs, which is strongly driving the bionic medical implants/artificial organs market. According to the National Kidney Foundation, around 121,678 people in the United States expected life-saving organ transplants in 2016. It is also reported that 17,107 kidney transplants were performed in the United States in 2014. bigger people. who are more prone to health problems such as eye diseases, gastrointestinal problems, orthopedic diseases, cancer and others.

Data Bridge Market Research analyzes that the market for bionic medical implants for artificial organs is expected to reach $37.75 billion by 2029, with a CAGR of 7.8% during the forecast period.

Market definition

Artificial organs and implants areprosthesisor devices specifically designed to be implanted in the human body to mimic the function of the original organ. The most important aspect of these implants is that they function like normal organs without interruption.

Report scope and market segmentation

Market dynamics of bionic medical implant artificial organs

conductor

• The increase in traffic accidents and injuries

The increasing number of accidents and injuries is one of the main factors behind the growth and demand for medical implants/bionic artificial organs. Furthermore, the rising prevalence of eye diseases along with an enhanced regulatory framework is driving the growth of the global market during the forecast period.

• The increase in the number of organ transplants

The rapid increase in the number of people waitingorgan transplantit also promotes market growth. Likewise, rising levels of organ failure due to aging and age-related diseases are driving the market growth during the forecast period.

• Public investments in health interoperability

Increased funding from the federal government to drive the adoption of these solutions continues to affect the market. Furthermore, rising healthcare spending, advances in healthcare infrastructure, and high demand for advanced healthcare are having a positive impact on the artificial bionic implant market.

occasions

Rapid technological advancement and increased government support will accelerate the expansion of the bionic medical implants/artificial organs market and provide significant growth opportunities for the market during the forecast period.

Limitations/Challenges

High equipment costs and uncertain reimbursement, as well as high development costs, will constrain the growth of the bionic medical implants/artificial organs market, while limited surgical experience may challenge market growth.

This Artificial Bionic Implants market report provides details on new developments, trade regulations, import-export analysis, production analysis, value chain optimization, market shares, impact of domestic and local market players, and discusses opportunities in terms of of emerging revenue streams. Changes in market regulation, strategic analysis of market growth, market size, category market growth, application and domain niches, product approvals, product launches, geographic expansion, technological innovations in the market. For more information on the market for bionic medical implants for artificial organs, contact Data Bridge Market Research to receive an analyst letter. Our team will help you make an informed market decision to achieve market growth.

Impact of COVID-19 on the artificial organ market for bionic medical implants

National lockdowns, government regulations and an increase in infection rates in all countries have had a significant financial impact on hospitals and neurology clinics. Several hospitals and clinics have seen a drop in patient visits as a result of COVID-19, reducing contact with clients. The shortage of potential organs for transplantation was a major problem. The demand for organ donors is constantly increasing and far exceeds the available supply. More than 120,000 people are waiting for a transplant in the United States, according to a 2019 report from the University of Pennsylvania. Bionics and artificial organs can meet the needs of people who need organ transplants and replacements. They have the ability to mimic the function of damaged organs.

Global market scope of artificial bionic implants

The market for bionic medical implants for artificial organs is segmented on the basis of product, attachment method, technology and end user. Growth in these Segments will help you analyze lean growth segments across industries, providing users with a valuable market overview and market insights to help them make strategic decisions to identify top market applications.

products

• bionic vision
• bionic ear
• orthopedic bionics
• heart bionics
• neurobiônica cerebral/neural

On a product basis, the artificial organ/bionic medical implant market is segmented into visual bionics, auditory bionics, orthopedic bionics, cardiac bionics, and neural/brain bionics. Bionic vision was subdivided into the bionic eye. Atrial bionics has been divided into cochlear implants and bone conduction hearing aids (BAHAs). Orthopedic bionics was subdivided into bionic limbs, bionic fingers, exoskeleton and electrical bone growth stimulators. Bionic limbs are divided into bionic hands and bionic legs. Bionic leg is divided into bionic knee and bionic feet. Electric bone growth stimulators are divided into invasive bone growth stimulators and non-invasive bone growth stimulators. Cardiac bionics has been subdivided into pacemakers, artificial hearts, cardiac assist systems, and artificial heart valves. The pacemaker is further divided into implantable pacemaker and external pacemaker. Artificial heart valves are divided into mechanical heart valves and tissue heart valves. The neural/brain bionics was subdivided into deep brain stimulator, vagus nerve stimulator and spinal cord stimulator.

fixing method

• implantable
• used externally

Based on the method of attachment, the bionic medical implants/artificial organs market is segmented into implantables and external use.

Technology

• electronic
• mechanically

On the basis of technology, the bionic medical implants/artificial organs market is segmented into electronic and mechanical segments.

final user

• hospitals and clinics
• academic and research institutes
• Others

The end-user segment of the bionic medical implants/artificial organs market is segmented into hospitals and clinics, academic and research institutes, and others.

Regional Analysis/Market Prospects for Bionic Medical Implants for Artificial Organs

Bionic Medical Implants for Artificial Organs market is analyzed, and market size information and trends are provided by country, product, attachment method, technology and end-user as stated above.

Countries covered in the Artificial Bionic Implants market report are USA, Canada and Mexico in North America, Germany, France, UK, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China , Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The North America region leads the bionic medical implants/artificial organs market due to the introduction of advanced bionic medical implants by major market players in the region. Asia-Pacific is expected to grow significantly in 2022-2029 due to the large number of patients, the growing demand for advanced treatments and the rapid development of health technology in this region.

The country section of the report also includes factors that influence the individual market and national regulatory changes that affect current and future market trends. Data points like downstream and upstream value chain analysis, technical trends and Porter's five forces analysis and case studies are some of the indicators used to forecast the market scenario for individual countries. It also considers the presence and availability of global brands and their challenges due to the high or low competition of local and national brands, the impact of national tariffs and commercial routes, at the same time that provides a forecast analysis of data from Country.

Health infrastructure growth Installed base and penetration of new technologies

Artificial Organs for Bionic Medical Implants market also provides detailed analysis of the market for each country, growth in healthcare capital equipment spending, installed base of different types of products for Artificial Organs market. Artificial organs for bionic medical implants, the impact of technology utilizing lifeline curves and changing healthcare regulatory landscapes and their impact on the market for bionic medical implants for artificial organs. Data are available for the historical period 2010-2020.

Bionic Medical Implants for Artificial Organs Market Share and Competitive Landscape Analysis

Artificial Organs for Bionic Medical Implants market competitive landscape includes details by competitor. Details included are company overview, company financials, revenue generated, market potential, R&D investments, new market initiatives, global presence, manufacturing locations and facilities, manufacturing capabilities, company strengths and weaknesses, launch of product, breadth and breadth of the product, domain of application. The data points provided above pertain only to the companies' approach to the Artificial Bionic Implants market.

Major Players in Artificial Organs for Bionic Medical Implants Market are:

• CONMED Corporation (USA)
• Wright Medical Group NV (EE. UU.)
• Stryker (United States)
• Medtronic (Irlanda)
• Smith + Nephew (UK)
• Zimmer Biomet (United States)
• Integra LifeSciences (EE. UU.)
• B. Braun Melsungen AG (Alemanha)
• Arthrex (United States)
• Baxter (United States)
• Medical Device Business Services, Inc. (EUA)
• Globe Medical (USA)
• DJO, LLC (USA)
• NuVasive, Inc. (USA)
• Orthopedic Implant Company (NV)
• Esculap Inc. (USA)
• Flexicare Medical Limited (UK)
• BioTek Instruments, Inc. (EE. UU.)
• Narang Medical Limited (India)
• Auxein Medical (India)
• Uteshiya Medicare (India)

Item number-15232